Tanja Schneider

University of Bonn — Germany

Medicine · Health Sciences

47h-index8.9kcitations146works11.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Microbial Natural Products and Biosynthesis(33), Biochemical and Structural Characterization(33), Antimicrobial Resistance in Staphylococcus(32), Antimicrobial Peptides and Activities(29), Bacterial Genetics and Biotechnology(22)

Publications146 total

A widespread SCC <i>mec</i> -located gene cluster protects methicillin-resistant <i>Staphylococcus aureus</i> against toxic polysulfides
2026Open Access
Characterization of the Cell Division-Associated Peptidoglycan Amidase AmiA of <i>Chlamydia trachomatis</i>
2025· 1 citedOpen Access
Trans-kingdom conservation of mechanism between bacterial actifensin and eukaryotic defensins
npj Antimicrobials and Resistance·2025Open Access
Antibiotic–Polycationic Peptide Conjugation as an Effective Strategy to Overcome Daptomycin Resistance (Adv. Therap. 5/2025)
Advanced Therapeutics·2025Open Access
Natural products chlorotonils exert a complex antibacterial mechanism and address multiple targets
Cell chemical biology·2025· 6 citedOpen Access
Antibiotic–Polycationic Peptide Conjugation as an Effective Strategy to Overcome Daptomycin Resistance
Advanced Therapeutics·2025· 3 citedOpen Access
The Dual Mode of Antibacterial Action of the Synthetic Small Molecule DCAP Involves Lipid II Binding
Journal of the American Chemical Society·2024· 5 citedOpen Access
Semisynthetic guanidino lipoglycopeptides with potent in vitro and in vivo antibacterial activity
Science Translational Medicine·2024· 15 citedOpen Access
Sophisticated natural products as antibiotics
Nature·2024· 98 citedOpen Access
A classic antibiotic reimagined: Rationally designed bacitracin variants exhibit potent activity against vancomycin-resistant pathogens
Proceedings of the National Academy of Sciences·2024· 21 citedOpen Access
Synthesis of Bisindole Alkaloids and Their Mode of Action against Methicillin-Resistant <i>Staphylococcus Aureus</i>
ACS Infectious Diseases·2024· 6 cited
The MraY Inhibitor Muraymycin D2 and Its Derivatives Induce Enlarged Cells in Obligate Intracellular Chlamydia and Wolbachia and Break the Persistence Phenotype in Chlamydia
Antibiotics·2024· 1 citedOpen Access
Abstract 5244: SIRPα knockout iPSC-derived macrophages (iMACs) are resistant to CD47-dependent inhibition of phagocytosis and efficiently kill tumor cells in pre-clinical models
Cancer Research·2024· 3 cited
<i>Staphylococcus epidermidis</i> bacteriocin A37 kills natural competitors with a unique mechanism of action
The ISME Journal·2024· 17 citedOpen Access
Altering glycopeptide antibiotic biosynthesis through mutasynthesis allows incorporation of fluorinated phenylglycine residues
RSC Chemical Biology·2024· 4 citedOpen Access
Biosynthesis of the corallorazines, a widespread class of antibiotic cyclic lipodipeptides
RSC Chemical Biology·2024· 1 citedOpen Access
1515 Gene edited iPSC-derived macrophages (iMACs) show increased phagocytosis in pre-clinical tumor models
2023· 1 citedOpen Access
An antibiotic from an uncultured bacterium binds to an immutable target
Cell·2023· 122 citedOpen Access
A new antibiotic from an uncultured bacterium binds to an immutable target
2023· 6 citedOpen Access
Abstract 3203: EVO<i>cells</i> Oncology: Tailored genetic engineering of iPSC-derived immune effector cells and combination with the right biologic therapeutics result in optimal killing of primary tumor cells from patients
Cancer Research·2023· 1 cited
page 1 of 8Next →

Frequent Co-authors

Hans‐Georg Sahl(24), Anna Müller(15), Fabian Grein(9), Imke Wiedemann(7), Daniela Münch(7), Ina Engels(6), Terry Roemer(5), Kim Lewis(4), Kevin C. Ludwig(4), Hans Georg Sahl(4), Mariana G. Pinho(4), Losee L. Ling(3), Aaron J. Peoples(3), Amy L. Spoering(3), Brian P. Conlon(3), Till F. Schäberle(3), Dallas E. Hughes(3), Anthony Nitti(3), Reinhard Wimmer(3), Julia P. Deisinger(3)